logo
Regaal Resources IPO Day 2 update: Subscription surpasses 16x, GMP at 29%

Regaal Resources IPO Day 2 update: Subscription surpasses 16x, GMP at 29%

Business Standard16 hours ago
Regaal Resources IPO Day 2 subscription status: The initial public offering (IPO) of maize speciality products manufacturer, Regaal Resources, which opened for public subscription on Tuesday, August 12, has received a favourable response from investors.
The NSE data suggests that the ₹306 crore offering of Regaal Resources received bids for 346.5 million equity shares, against 20.9 million shares on offer, resulting in a subscription of 16.5 times as of 1:20 PM on Wednesday, August 13.
Among the investor categories, non-institutional investors (NIIs) led the demand by oversubscribing the category reserved for them by 38.26 times. This was followed by retail investors, who bid for 14.83 times, and qualified institutional buyers (QIBs), for 3.11 times.
Regaal Resources IPO grey market premium (GMP)
The unlisted shares of Regaal Resources were commanding a decent premium in the grey market on the second day of its subscription window. Sources tracking unofficial market activities showed that Regaal Resources shares were trading at around ₹132 per share, reflecting a grey market premium (GMP) of ₹30 or 29.5 per cent over the upper end of the issue price.
Regaal Resources IPO review
Regaal Resources IPO details
The public offering is a book-built issue, which comprises a fresh issue of 20.6 million equity shares and an offer for sale (OFS) of 9.4 million shares. Regaal Resources IPO is available at a price band of ₹96 to ₹102 per share, and a lot size of 144 shares. Thus, investors can bid for a minimum of 144 shares of Regaal Resources IPO and in multiples thereof.
To bid for one lot or 144 shares of Regaal Resources IPO, a retail investor would require a minimum of ₹14,688, taking the upper end of the IPO price into consideration. A retail investor can bid for a maximum of 13 lots or 1,872 shares, amounting to ₹1,90,944.
The three-day subscription window to bid for the public offering is set to conclude on Thursday, August 14, 2025. Following the closure of the subscription window, the basis of allotment of Regaal Resources IPO shares is likely to get finalised on Monday, August 18, 2025, with shares getting credited into demat accounts by Tuesday, August 19, 2025.
Shares of Regaal Resources are set to make their D-Street debut tentatively on Wednesday, August 20, 2025, by listing on the BSE and NSE.
MUFG Intime India is the registrar of the issue. Pantomath Capital Advisors and Sumedha Fiscal Services are the book-running lead managers.
According to the red herring prospectus (RHP), the company plans to utilise the net fresh issue proceeds for the repayment or prepayment of certain debt and general corporate purposes.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

United Spirits Q1 profit slips 14 pc to  ₹417 cr; revenue at  ₹6,295 cr
United Spirits Q1 profit slips 14 pc to  ₹417 cr; revenue at  ₹6,295 cr

Mint

time6 hours ago

  • Mint

United Spirits Q1 profit slips 14 pc to ₹417 cr; revenue at ₹6,295 cr

New Delhi, Aug 13 (PTI) Diageo-controlled liquor maker United Spirits Ltd on Wednesday reported a 14 per cent decline in its consolidated net profit to ₹ 417 crore for the June quarter of FY26. The company had posted a net profit of ₹ 485 crore a year ago, according to a regulatory filing from United Spirits Ltd (USL). Its revenue from operations was marginally up at ₹ 6,295 crore during the quarter under review. It was ₹ 6,238 crore in the corresponding period of the previous fiscal. USL's total expenses stood at ₹ 5,776 crore, up 2.79 per cent in the June quarter. In the June quarter, "EBITDA was ₹ 644 crore, down 9.7 per cent, largely due to a one-off indirect tax item impact and relatively higher A&P in the standalone business", said USL in its earnings statement. In the June quarter, USL's income from the 'Beverage alcohol' segment rose 8.37 per cent to ₹ 2,549 crore. Its sports business, Royal Challengers Sports Private Ltd (RCSPL), which owns the RCB team for IPL and WPL, registered a 15.73 per cent growth in revenue to ₹ 478 crore in the June quarter. During the quarter, USL's consolidated net sales value (NSV) rose 9.4 per cent to ₹ 3,021 crore. "This was driven by the 8.4 per cent growth in the standalone business and 15.7 per cent reported growth of the sports business housed in the 100 per cent subsidiary RCSPL," it said. The Prestige & Above segment accounted for 88.3 per cent of net sales during the first quarter. The Popular segment accounted for 9.8 per cent of the net sales during the first quarter. The Popular segment net sales grew 13.6 per cent, it said. Its total income of USL, which owns brands like McDowell's, Royal Challenge, Signature, Johnnie Walker, and Black Dog in its fold, was ₹ 6,367 crore, up 1.5 per cent. "We delivered a resilient quarter with the Prestige & Above portfolio sustaining its growth momentum, while cycling a high prior year base. The quarter also marked the completion of the Nao Spirits acquisition. "Looking ahead, we remain focused on our circle of control to lead the next wave of category growth through sharper portfolio, tailored consumer engagement and revenue growth management," its Managing Director and CEO Praveen Someshwar said. Shares of United Spirits Ltd settled at ₹ 1,306.80 apiece on BSE on Wednesday, up 0.71 per cent from the previous close.

Max Healthcare to nearly double capacity to 9,500 beds by 2028 after strong quarterly growth
Max Healthcare to nearly double capacity to 9,500 beds by 2028 after strong quarterly growth

Time of India

time7 hours ago

  • Time of India

Max Healthcare to nearly double capacity to 9,500 beds by 2028 after strong quarterly growth

Max Healthcare Institute, India's largest healthcare chain by market cap, plans to nearly double its bed capacity to 9,500 in the next three years, Abhay Soi, chairman & managing director, told ET in an interaction on Wednesday. 'We increased our bed capacity by 35% from last year to 5,000. In the next 60 days, we will increase it to 6,000 through brownfield expansion. By 2028, it will go up to about 9,500,' said Soi. Finance Value and Valuation Masterclass - Batch 4 By CA Himanshu Jain View Program Artificial Intelligence AI For Business Professionals Batch 2 By Ansh Mehra View Program Finance Value and Valuation Masterclass - Batch 3 By CA Himanshu Jain View Program Artificial Intelligence AI For Business Professionals By Vaibhav Sisinity View Program Finance Value and Valuation Masterclass - Batch 2 By CA Himanshu Jain View Program Finance Value and Valuation Masterclass Batch-1 By CA Himanshu Jain View Program The company reported a 27% year-on-year growth in first quarter revenue to Rs 2,574 crore, led by an increase in occupied bed days (OBDs). Net profit for the quarter jumped 17% to Rs 345 crore, driven by higher occupancy and international patient inflow. Bed occupancy for the quarter was at 76%, with OBDs up by 26%. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Cardiologist Reveals: The Simple Morning Habit for a Flatter Belly After 50! Lulutox Undo Operating EBITDA rose 23% to Rs 613 crore, with margins at 24.9%. International patient revenue climbed 32% to Rs 208 crore, contributing about 9% of hospital revenue. During the quarter, the company completed a 160-bed tower at its Mohali hospital, signed a lease for a new 130-bed facility in Dehradun and agreed to sell two smaller hospitals in Bulandshahr and Anoopshahr for Rs 40 crore as part of its focus on super-specialty care in larger cities. Live Events Commenting on the growth levers, Soi said the biggest growth drivers today are the 'unsatiated' demand for quality healthcare and need for more capacity in the country, which will increase even further going ahead with an ageing population. 'Our sustained growth is a reflection of our strategy and execution capabilities,' said Soi. 'The commissioning of 160-bed brownfield tower at Max Mohali, along with additional brownfield capacities coming online at Max Smart and Nanavati-Max shortly, will significantly enhance clinical and financial performance of the network,' he added. 'In parallel, we are scaling up our clinical and support teams, while optimising our service mix to ensure rapid and effective utilisation of the new capacities,' he added. Going ahead the company will focus on a combination of brownfield and greenfield expansion to widen its network and meet the rising need for quality healthcare, said Soi. Shares of Max Healthcare Institute closed 0.44% up at Rs 1,267.60 apiece on the BSE on Wednesday. The company announced the earnings during market hours.

Kalpataru posts Rs 49 crore loss in Q1 FY26 despite strong pre-sales
Kalpataru posts Rs 49 crore loss in Q1 FY26 despite strong pre-sales

Business Standard

time8 hours ago

  • Business Standard

Kalpataru posts Rs 49 crore loss in Q1 FY26 despite strong pre-sales

Mumbai-based real estate developer Kalpataru reported a widening of losses to Rs 49.43 crore in the first quarter of FY26, compared with Rs 0.69 crore in Q1 FY25. Revenue from operations stood at Rs 443.2 crore, down 16.45 per cent year-on-year (Y-o-Y), while total expenses fell 5.18 per cent Y-o-Y to Rs 512.23 crore. The company follows the project completion method (PCM) for recognising revenue from projects launched after April 2022. Under this method, revenue is recorded only upon receipt of the occupation certificate (OC), whereas expenses such as marketing and corporate overheads are booked in the same quarter they are incurred. As of Q1 FY26, the majority of recognised revenue came from projects under PCM. Of its 24 ongoing projects, Kalpataru applies PCM to 13; however, costs associated with these projects are fully charged to the profit and loss account during the reporting period. Pre-sales rose 83 per cent Y-o-Y to Rs 1,249 crore, while collections increased 37 per cent YoY to Rs 1,147 crore. However, the area sold fell 9 per cent Y-o-Y to 0.56 million square feet. Average sales realisation during the quarter surged 101 per cent Y-o-Y to Rs 22,476 per square foot. The company has guided pre-sales of Rs 7,000 crore for FY26, up from Rs 4,531 crore in FY25. It is targeting collections of Rs 5,700 crore, compared with Rs 3,659 crore in the previous financial year. Debt reduction focus Net debt as of June 30, 2025, stood at Rs 7,939 crore. The net debt-to-equity ratio improved to 2.0x from 3.8x as of March 31, 2025. Kalpataru aims to reduce its debt to Rs 7,300 crore by the end of FY26. 'The company has utilised Rs 1,192.5 crore from IPO proceeds towards debt repayment, in line with the objects of the issue, and remains committed to further strengthening the balance sheet through continued debt reduction efforts,' said Parag Munot, Managing Director, Kalpataru. On a sequential basis, revenue declined 26 per cent. The company had posted a profit of Rs 14.05 crore in Q4 FY25, compared with a loss in the current quarter. Kalpataru shares closed at Rs 406.30 on the BSE on Tuesday.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store